Showing results (91-100 of 1,348) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|May 16, 2025
Pharmacokinetics and Safety Study of HN0141, a Novel Anti-Human Cytomegalovirus Inhibitor, in Healthy VolunteersGeorge Hill, Hong Gao, Yingzhe Fan, et al.
Clinical Pharmacology in Drug Development|May 12, 2025
Pharmacokinetic and Bioequivalence Evaluation of Prolonged-Release Octreotide Acetate Microspheres in Healthy Human SubjectsChenjing Wang, Xin Li, Xingli Gu, et al.
Clinical Pharmacology in Drug Development|May 10, 2025
A 2-Part, Open-Label, Phase 1 Bioequivalence and Food-Effect Study of Ubrogepant in Healthy Adult ParticipantsRamesh Boinpally, Joel M Trugman
Clinical Pharmacology in Drug Development|February 7, 2026
Clinical Significance of IL-4 and IL-21 Concurrent Elevation in Predicting Disease Activity Score and Antihistamine Treatment Response in Chronic Spontaneous UrticariaShining Wang, Xiaojing Yang, Xuming Zhao, et al.
Clinical Pharmacology in Drug Development|February 5, 2026
Bioequivalence and Pharmacokinetic Evaluation of Gliclazide Modified-Release Tablets in Healthy Chinese VolunteersKejia Fu, Chengcan Lu, Yuping Zhang, et al.
Clinical Pharmacology in Drug Development|February 13, 2026
Phase 1 Study Evaluating the Effects of Single-Dose Frespaciguat, an Inhaled Soluble Guanylate Cyclase Stimulator, Co-administered with Multiple-Dose Sildenafil on Systemic HemodynamicsEdnan K Bajwa, Dawn Cislak, John Palcza, et al.
Clinical Pharmacology in Drug Development|February 5, 2026
Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results from a Randomized, Open-Label, Parallel-Group StudyVincent Chow, Peter J Winkle, Daniel T Mytych, et al.
Clinical Pharmacology in Drug Development|February 14, 2026
Effect of Renal Impairment on the Pharmacokinetics and Safety of Doxecitine and Doxribtimine: A Single-Dose Phase 1 StudyAravind Mittur, Susan A VanMeter
Clinical Pharmacology in Drug Development|January 21, 2026
A Human Mass Balance and Metabolism Study of [14C]-Ubrogepant in Healthy Male AdultsRamesh R Boinpally, Joshua Rowe, Pushpa Chandrasekar, et al.
Clinical Pharmacology in Drug Development|January 16, 2026
Safety, Tolerability, and Pharmacokinetics of Mufemilast, a PDE4 Inhibitor, in Healthy Participants: A First-in-Human Phase 1 StudyXiuqi Li, Xiaofei Wu, Aihong Huo, et al.
Pageof 135